CtrlK

Command Palette

Search for a command to run...

Nureca

NSE: NURECABSE: 543264HEALTHCAREHEALTHCARE SUPPLIES
Market Cap
--
P/E Ratio
0.00
P/B Ratio
0.00
ROE
0.00%
ROA
0.00%
Debt/Equity
0.00
Book Value
₹0.0
EPS
₹0.0

About Nureca

Nureca is engaged in the business of home healthcare and wellness products. Nureca Limited was formerly incorporated as Nureca Private Limited in India on 02 November 2016 under the provisions of Companies Act, 2013. The Company got converted from Private Limited Company to a Public Limited Company with effect from 08 July 2020 and the name of Company was changed to Nureca Limited. Nureca is a digitally native, consumer healthcare company with a leading presence in categories such as home diagnostics, wellness devices, and personal fitness equipment under brands like Dr Trust and Dr Physio. The Company's differentiated strategy is built around four pillars: Product Innovation, Omnichannel Distribution, Direct-to-Consumer (D2C) Excellence and In-House Manufacturing Capabilities. The Company is engaged in the business of home healthcare and wellness products. Nureca is a digital first, B2C company. The Company sell products through implementation of various digital online platform channels like Flipkart, Amazon and website http://drtrust.in/. Dr. Trust is a pioneer in global healthcare and wellness brand with patented technologies and innovative solutions, helping users monitor chronic ailments. The Company focused on leveraging its innovation, research, and data science capabilities to help and empower more people living with chronic and lifestyle diseases to live healthier and happier lives. In 2017, the Company commenced business operations and launched 'Dr. Trust' brand through digital healthcare channel. In 2018, the Company widened product basket with launching of brands in electric massages and mother & child care categories like Dr. Physio and Trumom. The Company started three flex centers in Punjab, Karnataka and Uttar Pradesh. In 2019, the Company took the initiative for commencing business with WS retail. It increased the aggregate number of SKUs to 150. The Company added three flex centers in Tricity Chandigarh, Telangana and Maharashtra. The Company's key products secured a warehouse drug license. In 2020, Company expanded presence through different channels and took initiative for starting business with 1mg, Pharmeasy, Paytm, and Croma retail stores. The Company had taken the effect of demerger as per the Scheme of Arrangement among Nectar Biopharma Private Limited and the Company and their respective shareholders and creditors and the Scheme became effective on 23 May 2020. Pursuant to Scheme of Demerger, certain portion of business activities of Nectar Biopharma Private Limited was transferred by Nectar Biopharma Private Limited from 01 April, 2019. Nureca Technologies Private Limited have received industrial policy approval to establish a health and wellness equipment manufacturing plant at Village Sundra, SAS Nagar, Punjab in FY 25.

Price Action • NURECA

Financial Statements

Consolidated & Standalone Reports

MetricTTMMar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
Total Revenue
152.81127.18105.08119.06263.27216.15101.790.730.590.02
Operating Expenses
139.05124.37105.65127.29199.78151.6592.360.70.560.02
Operating Profit
4.5-9.73-11.13-15.3955.7761.689.360.030.020
Operating Margin (%)
--7.65-10.59-12.9321.1828.549.24.374.2110.05
Total Expenses
-127.64108.35130.02201.94153.6693.140.70.570.02
EBITDA
-2.81-0.57-8.2263.4964.59.420.030.020
EBITDA Margin (%)
-2.21-0.54-6.9124.1229.849.264.74.2110.05
Interest Expenses
1.381.120.460.430.731.60.7000
Depreciation
1.892.152.242.31.430.410.08000
Profit Before Tax (PBT)
10.49-0.46-3.27-10.9661.3362.498.640.030.020
Tax Expenses
1.490.21-0.83-2.5416.0215.962.220.010.010
PAT Before Extraordinary Items
--0.67-2.44-8.4245.3146.536.420.020.020
Net Profit
9-0.67-2.44-8.4245.3146.536.420.020.020
Net Profit Margin (%)
--0.58-2.58-7.5217.7321.816.312.842.651.23
EPS (Adjusted)
--0.67-2.44-8.4245.3146.536.420.020.020

Valuation & Key Ratios

Performance Metrics

MetricTTMMar '25Mar '24Mar '23Mar '22Mar '21Mar '20Mar '19Mar '18Mar '17
Book Value Per Share
-192.48192.86195.26203.74163.29149.946.6425.8810.24
Return on Assets (ROA) %
--0.32-1.19-4.0720.6325.0320.571.624.660.29
Return on Equity (ROE) %
--0.34-1.26-4.3122.2328.4942.8544.4960.422.38
Return on Capital Employed (ROCE) %
-0.33-1.43-5.3129.9138.3538.6764.6391.89.61
Profitability Ratios
----------
Liquidity Ratios
----------
Valuation Ratios
----------
Debt to Equity Ratio
-0.010000.020.61000

Featured Insight

No recent news available

Key People

A
Aryan Goyal
Executive Director,Whole Time Director,Chief Executive Officer
M
Mr. Naresh Gupta
Chief Financial Officer
M
Ms. Chetna Ananad
Company Secretary
N
Nishu Kansal
Company Secretary

Frequently Asked Questions